Bjerkvig Rolf, academician of the European Academy of Sciences, tenured professor at the University of Bergen, Norway, part-time chair professor at Shandong University, is a world-renowned expert on neuro-oncology, a pioneer in neuro-oncology research, director of the Brain Tumor Research Center at the University of Bergen, Norway, and Director of the Luxembourg Institute for Health Research. Professor Bjerkvig has been engaged in cancer biology research since the 1980s, and is particularly knowledgeable in the study of brain gliomas. He is a worldwide pioneer in this profession and was the first to propose the concept of Neuro-Oncology (neuro-oncology). made great contributions to its promotion and development. Under his leadership, his team has published more than 260 SCI articles, many of which were published in high academic impact journals such as Nature and Cell. He has authored 2 monographs, participated in the preparation of 22 professional books, and obtained patents. 2 items to create a tumor immunotherapy company. He is the leader of the "Angiotargeting" project of the European Union's Sixth Framework Program; he has received a series of major grants from the Norwegian Research Council, the Norwegian Cancer Society and the European Commission. He has received many research awards in professional fields, including the 2015 King Olav V Cancer Research Award of Norway. This award is the highest national award in Norway. Only those who have made great contributions in the field of scientific research can receive this award.